COVID-19 has resulted in over 100 million infections and caused worldwide lock downs due to its high transmission rate and limited testing options. Current diagnostic tests can be expensive, limited in availability, time-intensive and require risky in-person appointments. It has been established that symptomatic COVID-19 seriously impairs normal functioning of the respiratory system, thus affecting the coughing acoustics. The 2021 DiCOVA Challenge @ INTERSPEECH was designed to find scientific and engineering insights to the question by enabling participants to analyze an acoustic dataset gathered from COVID-19 positive and non-COVID-19 individuals. In this report we describe our participation in the Challenge (Track 1). We achieved 82.37% AUC ROC on the blind test outperforming the Challenge's baseline of 69.85%.
翻译:COVID-19导致1亿多人感染,并因其高传播率和有限的测试选择而导致全球封闭。目前的诊断测试费用昂贵,可用性有限,时间密集,需要人员上岗的风险。已经证实,COVID-19症状严重损害了呼吸系统的正常功能,从而影响咳嗽声学。2021年DiCOVA挑战@INTESPEECH的设计目的是通过让参与者分析从COVID-19阳性和非COVID-19个人收集的声学数据集,找到对这个问题的科学和工程见解。我们在本报告中描述了我们参与挑战的情况(轨道1):我们通过盲测取得了82.37 %的ACUCROC,使挑战的基线达到69.85%。